You are here

Pathogen Specific Antimicrobial Coatings for Fabrics

Award Information
Agency: Department of Defense
Branch: Army
Contract: W911NF-14-P-0027
Agency Tracking Number: A14A-012-0014
Amount: $149,967.00
Phase: Phase I
Program: STTR
Solicitation Topic Code: A14A-T012
Solicitation Number: 2014.A
Solicitation Year: 2014
Award Year: 2014
Award Start Date (Proposal Award Date): 2014-08-20
Award End Date (Contract End Date): 2015-02-18
Small Business Information
89 Rumford Avenue
Newton, MA 02466-1311
United States
DUNS: 066594979
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Avni Argun
 Senior Program Scientist
 (781) 529-0581
Business Contact
 Anthony Vaccaro
Title: President/COO
Phone: (781) 529-0504
Research Institution
 Texas A&M University
 Travis Young
400 Harvey Mitchell Pkwy South Suite 300, 3578 TAMUS
College Station, TX 77845-4375
United States

 (979) 845-0209
 Nonprofit college or university

Antimicrobial treatment of military textile systems is intended to provide enhanced protection to the Warfighter in the field by preventing colonization of harmful bacteria that cause problems such as odor, dermatitis, and skin irritation. Current treatments can impart antimicrobial functionality to textiles; however, they all possess broad-spectrum antimicrobial activity, affecting all skin bacteria. The processing of these compounds is also costly with high environmental impact. Bio-derived antimicrobial coatings offer selective elimination of targeted bacteria without effecting commensal bacteria required for skin health. There is considerable interest in using bacteriophages, the viruses of bacteria, as antimicrobials to control pathogenic bacterial populations. They can uniquely offer specificity against targeted bacteria and they can be optimized for maintenance of antibacterial effect in textile coating materials. By judicious selection of bacteriophages and biocompatible polymers, this program will develop robust antimicrobial coatings with high efficacy and bacterial selectivity. The focus of the work will be the validation of bacteriophage efficacy and demonstration of large-scale production. Using a novel processing method, a series of bacteriophage coatings will be formed and tested against select bacterial colonies. The coating method will offer fast processing speeds for high-volume production at low costs.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government